Skip to search formSkip to main contentSkip to account menu

Receptor Down-Regulation

Known as: Down-Regulation, Receptor, Receptor Down Regulation, receptor downregulation 
A negative regulatory process that decreases ligand-receptor interactions. Reduction in receptor binding after ligand exposure can result from the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
On binding to its receptor, epidermal growth factor (EGF) initiates a cascade of events leading to cell proliferation or… 
1998
1998
In summary, beta 2-adrenergic agonists and corticosteroids can interact to produce beneficial effects on airway function. The… 
1995
1995
Background Cardiac contractile force in response to β-adrenoceptor agonists and β-adrenergic receptor density are decreased in… 
1993
1993
Long-term stimulation of the beta 2-adrenergic receptor (beta 2AR) leads to an internalization and degradation of the receptor… 
1992
1992
Apical membrane ion channels control the rate of transepithelial electrolyte transport in many epithelia. One way to study such… 
1990
1990
Intact cultured human foreskin fibroblasts can be used as an in vitro system to study the regulatory events related to kinin… 
1989
1989
TCDD was found to cause a marked inhibition of 125I-epidermal growth factor (EGF) binding to its receptor on the cell surface of… 
1986
1986
The effects of cell aging on insulin binding and on insulin receptor processing in human erythrocytes were studied. Erythrocytes… 
1985
1985
Several ligands, including epidermal growth factor (EGF), have been found to negatively modulate or down‐regulate their specific… 
1981
1981
Nicotinamide (50mM) prevented insulin-mediated down-regulation of insulin receptors in IM-9 lymphoblastoid cells. Half-maximum…